Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrative Genomic Tests in Clinical Oncology
Evgeny N. Imyanitov, Anna P. Sokolenko
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13129-13129
Open Access | Times Cited: 19

Showing 19 citing articles:

Targeting of TAMs: can we be more clever than cancer cells?
Julia Kzhyshkowska, Jiaxin Shen, Irina Larionova
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1376-1409
Open Access | Times Cited: 11
Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker
Yanxing Li, Wentao Gao, Zhen Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
NGS as an auxiliary tool for differential diagnosis of solid tumors: a clinical case and literature review
R. I. Absalyamov, Yu. N. Savenko, Egor Veselovsky, et al.
Malignant tumours (2025)
Closed Access
Decoding driver and phenotypic genes in cancer: Unveiling the essence behind the phenomenon
Dequan Liu, Lei Liu, Xiaoman Zhang, et al.
Molecular Aspects of Medicine (2025) Vol. 103, pp. 101358-101358
Open Access
Overview on biomarkers for immune oncology drugs
Evgeny N. Imyanitov, Elena V. Preobrazhenskaya, Natalia V. Mitiushkina
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Clinical Utility of Large Next-Generation Sequencing Panel Across Diverse Tumour Types: A Single-Center Retrospective Analysis
HP Chen, Guo Zy, Limei Zhang, et al.
Nigerian Journal of Clinical Practice (2025) Vol. 28, Iss. 3, pp. 352-359
Closed Access
HSP110 T17 Marker Matches the Pentaplex Panel and Outperforms CAT-25 For Detecting Microsatellite Instability in sporadic Colorectal Cancer
Nasreddine Rajoua, Antoine Daunay, Wissem Triki, et al.
Cancer Genetics (2025) Vol. 294-295, pp. 21-26
Closed Access
Personalised neoantigen‐based therapy in colorectal cancer
Yajuan Zhu, Xiong Li, Ting‐Ting Chen, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 11
Open Access | Times Cited: 9
Agnostic Administration of Targeted Anticancer Drugs: Looking for a Balance between Hype and Caution
Svetlana N. Aleksakhina, A.O. Ivantsov, Evgeny N. Imyanitov
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4094-4094
Open Access | Times Cited: 2
Bioinformatics Analysis of Programmed Cell Death in Spinal Cord Injury
Xuegang He, Bo Deng, Miao Ma, et al.
World Neurosurgery (2023) Vol. 177, pp. e332-e342
Open Access | Times Cited: 5
Biomarker Testing Journey Among Patients with Advanced Solid Tumors and Treatment Patterns by Homologous Recombination Repair Status: A Clinico-Genomic Database Study
Changxia Shao, Yixin Ren, Heng Zhou, et al.
Advances in Therapy (2024) Vol. 41, Iss. 2, pp. 759-776
Closed Access
HRD-negative high-grade carcinoma of the ovary in <i>BRCA2</i> pathogenic variant carrier
Anna P. Sokolenko, Svetlana Poletaeva, Anna D. Shestakova, et al.
Siberian Journal of Oncology (2024) Vol. 23, Iss. 2, pp. 139-146
Open Access
Integrating Bulk and Single-Cell RNA-Seq Data to Identify Prognostic Features Related to Activated Dendritic Cells in Clear-Cell Renal-Cell Carcinoma
Zijian Ye, Yifan Zhang, Jialiang Xu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9235-9235
Open Access
The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory
NIKOLAOS TSOULOS, Κωνσταντίνος Αγιαννιτόπουλος, Kevisa Potska, et al.
Cancer Genomics & Proteomics (2024) Vol. 21, Iss. 5, pp. 448-463
Open Access
Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing
Deshui Kong, Yu Wu, Qiyu Liu, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Clinical characterization and genomic landscape of gynecological cancers among patients attending a Chinese hospital
Cen Jiang, Yiyi Lu, Hua Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?
Giuseppe Fanciulli, Roberta Modica, Anna La Salvia, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 1
Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients
Benoît Mazel, Geoffrey Bertolone, Amandine Baurand, et al.
Cancer Medicine (2023) Vol. 12, Iss. 18, pp. 18786-18796
Open Access | Times Cited: 1
Bioinformatics analysis of programmed cell death in spinal cord injury
Xuegang He, Bo Deng, Miao Ma, et al.
Research Square (Research Square) (2023)
Open Access
Prédisposition héréditaire au cancer colorectal et inactivation de la fonction de réparation des mésappariements de l’ADN
Sylviane Olschwang, Philippe Grandval
EMC - Gastro-entérologie (2023) Vol. 40, Iss. 3, pp. 1-10
Closed Access
Page 1

Scroll to top